Since its foundation in 1847, Hisamitsu Pharmaceutical, Japan’s leading pain relief patch manufacturer, have dedicated themselves to improving the quality of life of people around the world by promoting the numerous benefits of pain relief patches featuring transdermal drug delivery systems (TDDS). At present, Hisamitsu’s network of offices, R&D and manufacturing facilities has spread to ten countries on four continents and employs over 2,600 people. Each year, Hisamitsu manufactures 3.3 billion patches worldwide.
Hisamitsu’s mainstay and flagship brand - Salonpas® - is sold in 50 countries worldwide, with brand leadership in South-East Asia and the USA. Salonpas® is the first and only OTC topical analgesic patch to be approved by the US Food & Drug Administration (FDA) in 2008.